Clinical Trials Browser

Phase 1/2 × Has results × peposertib × Clear all

NCT03770689 2023-03-21

Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer

Phase 1/2 Completed

19 enrolled 21 charts

Gastrointestinal

Locally Advanced Rectal Cancer